BioCentury
ARTICLE | Company News

Management tracks

May 3, 2017 11:41 PM UTC

Immunotherapy company GammaDelta Therapeutics Ltd. (London, U.K.) named Paolo Paoletti CEO, Natalie Mount CSO, and Dayle Hogg COO. Paoletti and Hogg both joined GammaDelta from Kesios Therapeutics Ltd. (London, U.K.), where Paoletti was CEO and Hogg COO. Mount was chief clinical officer at Cell and Gene Therapy Catapult (London, U.K.). Paoletti replaced interim CEO and commercial founder Raj Mehta, who became director of intellectual property, alliance management and business development.

Gene therapy company GenSight Biologics S.A. (Euronext:SIGHT) named Mohamed Genead CMO. He was VP and global therapeutic area head for ophthalmology and retina gene therapy at Biogen Inc. (NASDAQ:BIIB). ...